Article

Robin Roberts Provides an Update on Her Partner’s Cancer, Supreme Court Rejects Bayer’s Roundup Appeals and More

Author(s):

From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.

“Good Morning America” host Robin Roberts provides an update on her partner’s cancer.

Robin Roberts delivering the keynote speech at CURE®'s 2018 Extraordinary Healer gala.

Robin Roberts delivering the keynote speech at CURE®'s 2018 Extraordinary Healer gala.

Robin Roberts, the host of “Good Morning America” and a cancer survivor herself, gave an update on her partner, Amber Laign, who was diagnosed with breast cancer last year.

Roberts shared a video in Instagram informing viewers that Laign had a rough week.

“God didn’t create you to be overcome, He created you to become an overcomer,” Roberts said during her “morning prayer and message” clips on social media. “(Amber) had such a challenging week last week, thank you for allowing me the time to be with her. But it’s a brand new week — overcome it.”

Supreme Court rejects an appeal to stop lawsuits around Roundup weed killer.

In late 2015, lawsuits began piling up claiming that the weed killer Roundup was causing cancer. Then, in 2018, the first verdict was reached with a California resident being awarded $289 million after arguing that his diagnosis of non-Hodgkin lymphoma was linked to the exposure to Roundup’s key ingredient, glyphosate. After Bayer (the manufacturer of Roundup) agreed to take glyphosate out of Roundup’s formula, the company is now urging the courts to put an end to the thousands of lawsuits surrounding Roundup.

However, the Supreme Court rejected Bayer’s appeal and will move forward with lawsuits, despite an Environmental Protection Agency finding from 2020 claiming that glyphosate is “not likely” to lead to a serious health risk. The appellate court also ordered the agency to reevaluate this finding, as the International Agency for Research on Cancer determined in 2015 that glyphosate is “probably carcinogenic (cancer-causing) to humans.”

A statue of a mother with metastatic breast cancer was erected in front of the Norwegian Parliament.

The Norwegian Breast Cancer Society teamed up with the Association of Norwegian Sculptors to create a statue of Cecile, a 44-year-old mother of three who has metastatic breast cancer. According to the Norwegian Breast Cancer Society, the purpose of the statue — which is now displayed outside of the Norwegian Parliament — is to raise awareness for incurable breast cancer.

"This statue is a monument to women with metastatic breast cancer and a call to all of us to give extra care, attention, and support to the affected patients," said Ellen Harris Utne, chair of the board of the Norwegian Breast Cancer Society.

Lebanese dancers honor an “America’s Got Talent” contestant who died of cancer.

This week, a group of dancers from Lebanon auditioned for “America’s Got Talent,” stating that a former contestant on the show, Jane Marczewski (AKA Nightbirdie) is their inspiration.

Marczewski moved judges to tears when she competed in the show last year, earning a golden buzzer from judge Simon Cowell. However, the singer had to leave the show last August as her health was declining. She died in February.

“Lebanon is not considered a place where you can build a career out of dancing. It’s hard, really hard — and harder for women,” choreographer and founder Nadim Cherfan, said. “I grew up watching America’s Got Talent, and I was inspired by so many people, but what really got us to audition this year is Nightbirdie, when she said, ‘You can’t wait until life isn’t hard anymore before you decide to be happy.’”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Image of man with grey hair.
Image of woman with blonde hair.
Related Content